Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
National Storage Affiliates Trust Announces Quarterly Dividends
-
BILL to Participate in Upcoming Investor Conferences
-
Arcadium Lithium's CEO Paul Graves to Speak at Multiple Upcoming Conferences in the Second Quarter
-
Box Announces Appointment of Steve Murphy, CEO of Epicor Software, to its Board of Directors
-
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Interface Declares Regular Quarterly Dividend
-
Domo Announces New Omnichannel Optimization Solutions For Retailers
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
-
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
-
Build-A-Bear Workshop to Announce First Quarter Fiscal 2024 Results and Host Investor Conference Call on May 30, 2024
-
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
-
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets
-
Savara Announces New Employment Inducement Grant
-
Rapid7 to Attend Upcoming Investor Conferences
-
Epsilon Announces 2024 AGM Results
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
-
Ulta Beauty to Report First Quarter Fiscal 2024 Results on May 30, 2024
-
ZimVie to Participate in Upcoming Investor Conferences
-
TEN Ltd. Announces Delivery of Six Environmentally Friendly Vessels Since the Beginning of 2024
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Earlyworks Announces Completion of ADS Ratio Change
-
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
-
Metropolitan Issues Statement on Release of New Cost Estimate for Delta Conveyance Project
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
-
It's Summertime at Cold Stone Creamery!
-
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
-
Legend Power Systems Schedules Q2 2024 Financial Results Release and Webinar
-
Applied Materials Announces Second Quarter 2024 Results
-
Unity Bancorp Declares Cash Dividend
-
Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655
-
Adagio Medical Announces First European Commercial Procedures and Commencement of U.S. FDA Pivotal IDE for Ventricular Tachycardia Cryoablation System
-
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
-
Air Industries Group Receives Orders of $8.2 Million for Components Used on UH-60 Black Hawk and H-92 Helicopters
-
CSG Systems International Approves Quarterly Dividend
-
Rent the Runway to Report First Quarter 2024 Results on June 6, 2024
-
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
-
FormFactor Announces Participation at Upcoming Conferences
-
Galapagos creates new subscription right plans
-
Broadside Enterprises, Inc. (OTC: BRSE), Poised to be a Leader in the Rapidly Growing Food Delivery Market, Announces Q1 2024 Results
-
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech
-
Innovative Solutions & Support, Inc. Appoint New Board Member
-
Erpminer, a digital currency mining machine company, has announced its entry into the Kenyan market to develop its online presence and support the country's economic transformation and growth.
-
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
-
Texas Capital Bancshares, Inc. Appoints Mark Midkiff to Board of Directors
-
CareQuest Institute CEO Testifies at Senate Committee Hearing on Dental Care Crisis in US
-
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH

